This Article Full Text Full Text (PDF) All Versions of this Article: 105/9/1037    most recent hc0902.104713v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Li, H. Articles by Goligorsky, M. S. Search for Related Content PubMed PubMed Citation Articles by Li, H. Articles by Goligorsky, M. S. Related Collections Endothelium/vascular type/nitric oxide Mechanism of atherosclerosis/growth factors

(Circulation. 2002;105:1037.)
© 2002 American Heart Association, Inc.

Clinical Investigation and Reports

Homocysteine Induces 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase in Vascular Endothelial Cells

A Mechanism for Development of Atherosclerosis?

Hong Li, MD; Avalyn Lewis, BS; Sergey Brodsky, MD, PhD; Robert Rieger, BS; Charles Iden, PhD; Michael S. Goligorsky, MD, PhD

From the Departments of Medicine, Physiology, and Biophysics (H.L., S.B., M.S.G.) and Pharmacological Sciences (A.L., R.R., C.I.), State University of New York, Stony Brook, NY.

Correspondence to Hong Li, MD, Department of Medicine, State University of New York, Stony Brook, NY 11794-8152. E-mail hongli888{at}yahoo.com

Background— It has been established that hyperhomocyst(e)inemia (HHCy) is an independent and graded risk factor for atherosclerosis, although the molecular link to the atherosclerotic process remains obscure.

Methods and Results— Screening human umbilical vein endothelial cells (HUVECs) with complementary DNA microarray for the gene expression modified by homocysteine (Hcy) revealed that 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) was upregulated. This effect was confirmed using quantitative reverse transcriptase-polymerase chain reaction. Actinomycin D studies revealed that Hcy stabilized HMGCR mRNA (_1/2, 9.5±1.0 versus 5.0±0.2 hours). Expression of immunodetectable HMGCR in both HUVECs and renal microvascular endothelial cells was increased in Hcy-treated cells in association with the increased abundance of caveolin. Application of a cell-permeable superoxide dismutase mimetic, Mn-TBAP, reversed the Hcy-induced expression of HMGCR. Additional biochemical analysis of the abundance of total cellular cholesterol showed that 0, 20, 50, and 100 µmol/L Hcy resulted in 22.2±7.3%, 39.5±1.2%, and 50.4±6.8% increase, respectively. Gas chromatography mass spectrometry analysis of extracted cholesterol from Hcy-treated HUVECs and from the culture medium showed 17.8±5.2% and 24.0±14.5% increases, respectively. Application of simvastatin to Hcy-treated cells reduced cellular cholesterol and prevented Hcy-induced suppression of NO production by HUVECs in a dose-dependent manner.

Conclusions— Using a cDNA microarray, the data disclosed an unexpected link between Hcy and cholesterol dysregulation based on the finding of increased abundance of HMGCR mRNA and protein in endothelial cells, demonstrated the possible role of Hcy-induced oxidative stress in this response, and revealed the improvement of endothelial NO production in Hcy-treated HUVECs by statins. Collectively, these findings may provide a solid explanation for the observed proatherogenic effect of HHcy.

Key Words: endothelium • cholesterol • statins • nitric oxide

This article has been cited by other articles:

				M. S. Goligorsky Frontiers in Nephrology: Viewing the Kidney through the Heart Endothelial Dysfunction in Chronic Kidney Disease J. Am. Soc. Nephrol., November 1, 2007; 18(11): 2833 - 2835. [Full Text] [PDF]

				B. Bartali, R. D. Semba, E. A. Frongillo, R. Varadhan, M. O. Ricks, C. S. Blaum, L. Ferrucci, J. M. Guralnik, and L. P. Fried Low Micronutrient Levels as a Predictor of Incident Disability in Older Women Arch Intern Med, November 27, 2006; 166(21): 2335 - 2340. [Abstract] [Full Text] [PDF]

				A. Zulli, B. F. Buxton, M. J. Black, Z. Ming, A. Cameron, and D. L. Hare The Immunoquantification of Caveolin-1 and eNOS in Human and Rabbit Diseased Blood Vessels J. Histochem. Cytochem., February 1, 2006; 54(2): 151 - 159. [Abstract] [Full Text] [PDF]

				M. S. Goligorsky Endothelial cell dysfunction: can't live with it, how to live without it Am J Physiol Renal Physiol, May 1, 2005; 288(5): F871 - F880. [Abstract] [Full Text] [PDF]

				M. Soinio, J. Marniemi, M. Laakso, S. Lehto, and T. Ronnemaa Elevated Plasma Homocysteine Level Is an Independent Predictor of Coronary Heart Disease Events in Patients with Type 2 Diabetes Mellitus Ann Intern Med, January 20, 2004; 140(2): 94 - 100. [Abstract] [Full Text] [PDF]

				C Napoli, L O Lerman, V Sica, A Lerman, G Tajana, and F de Nigris Microarray analysis: a novel research tool for cardiovascular scientists and physicians Heart, June 1, 2003; 89(6): 597 - 604. [Abstract] [Full Text] [PDF]

				F. M. Faraci Hyperhomocysteinemia: A Million Ways to Lose Control Arterioscler. Thromb. Vasc. Biol., March 1, 2003; 23(3): 371 - 373. [Full Text] [PDF]